The Amplatzer Paraclose PVL Occluder [Image courtesy of Abbott] Abbott (NYSE: ABT) has secured an FDA approval for a ...
Revenue climbed over 7% to $5.5 billion, surpassing analysts’ consensus of $5.35 billion. GE HealthCare shares rose over 7% on Wednesday morning following the report. “We delivered strong top-line ...
Albert White stepped down as CEO, while former Steris chief Walter Rosebrough will run the business until a replacement is ...
CEO Mike Mahoney said the upcoming years will be a time of restructuring for Boston Scientific, following layoffs and ...
B. Braun and the FDA notified customers of an issue affecting Streamline bloodline sets, which could cause connectors to ...
Philips' first chief AI officer, Shez Partovi, discussed how his role will depart from his previous work as chief innovation ...
Elin Frostehav will be leaving the Swedish medtech after it saw the departure of its life sciences president announced ...
Abbott’s next-gen Oncodetect molecular residual disease (MRD) test detects traces of circulating tumor DNA in a patient’s ...
The loan facility from Perceptive Advisors follows FDA clearances in high-volume outpatient procedures for Distalmotion's ...
ZuriMed’s FDA-cleared FiberLocker implant reinforces rotator cuff repairs, and is bound for Stryker's sports medicine ...
Elucid received FDA clearance for its AI-powered FFR-IQ software, which provides a noninvasive estimate of fractional flow ...
Zimmer Biomet recently announced a multi-year extension of its limited, exclusive distribution and supply agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results